Article info
PDFPostScript
Letter
Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
- Correspondence to Dr Alexandre Pariente, Unité d'hépatogastroentérologie, Centre Hospitalier, Boulevard Hauterive, Pau 64000, France; alex.pariente{at}free.fr
Citation
Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
Publication history
- Received December 1, 2013
- Accepted December 7, 2013
- First published January 2, 2014.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions